The Centers for Disease Control and Prevention (CDC) have received numerous questions following the July 2019 release of the enhanced barrier precautions. In response, the CDC has released a frequently asked questions website in reference to the enhanced barrier precautions (EBPs) and multidrug resistant organisms (MDROs). The frequently asked questions (FAQs) include discussion about the definition and scope of the EBPs, application and duration of EBPs, and implementation of EBPs. The FAQs can be found on the following website: https://www.cdc.gov/hai/containment/faqs.html
Tuesday, December 3, 2019
CDC Releases FAQs about Enhanced Barrier Precautions and Multidrug-Resistant Organisms
Pamela Truscott
The Centers for Disease Control and Prevention (CDC) have received numerous questions following the July 2019 release of the enhanced barrier precautions. In response, the CDC has released a frequently asked questions website in reference to the enhanced barrier precautions (EBPs) and multidrug resistant organisms (MDROs). The frequently asked questions (FAQs) include discussion about the definition and scope of the EBPs, application and duration of EBPs, and implementation of EBPs. The FAQs can be found on the following website: https://www.cdc.gov/hai/containment/faqs.html
The Centers for Disease Control and Prevention (CDC) have received numerous questions following the July 2019 release of the enhanced barrier precautions. In response, the CDC has released a frequently asked questions website in reference to the enhanced barrier precautions (EBPs) and multidrug resistant organisms (MDROs). The frequently asked questions (FAQs) include discussion about the definition and scope of the EBPs, application and duration of EBPs, and implementation of EBPs. The FAQs can be found on the following website: https://www.cdc.gov/hai/containment/faqs.html
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment